New Additions to Drugs.com for 2003
We update the Drugs.com database on a regular cycle. The following new drug information was added in 2003:
Jan 1, 2003 - (laronidase) a man-made form of the naturally-occurring enzyme alpha-L-iduronidase. A deficiency of this enzyme is called mucopolysaccharidosis I (MPS I). Laronidase helps the body break down certain products that may lead to damage in the tissues and organs. Used in the treatment of mucopolysaccharidosis disease.
Jan 1, 2003 - (palonosetron) is a 5-HT3 receptor antagonist which works by blocking the actions of chemicals in the body that may cause nausea and vomiting. Palonosetron is used to prevent nausea and vomiting associated with cancer chemotherapy.
Jan 1, 2003 - (alefacept) a protein that reduces specific actions of the immune system that are involved in causing psoriasis. Used for the treatment of moderate to severe chronic plaque psoriasis in people who are candidates for systemic therapy or phototherapy.
Jan 1, 2003 - (tadalafil) is used to treat erectile dysfunction.
Jan 1, 2003 - (ciprofloxacin and dexamethasone otic) ciprofloxacin is a fluoroquinolone antibiotic (used to fight bacteria in the body) and dexamethasone is a steroid (used to reduce inflammation caused by an infection). Together, ciprofloxacin and dexamethasone are used to treat ear infections.
Jan 1, 2003 - (rosuvastatin) is in a class of drugs called HMG-CoA reductase inhibitors, which block the production of cholesterol in the body. Rosuvastatin is used to reduce the amounts of LDL (bad) cholesterol, total cholesterol, triglycerides (another type of fat), and apolipoprotein B (a protein needed to make cholesterol) in the blood. Rosuvastatin also increases the level of HDL (good) cholesterol in the blood. These actions are important in reducing the risk of atherosclerosis (fatty deposits in the arteries), which can lead to heart attack, stroke, and peripheral vascular disease.
Jan 1, 2003 - (daptomycin) is an antibiotic used to treat bacterial infections of the skin and underlying skin structures.
Jan 1, 2003 - (epinastine ophthalmic) is an anti-allergic medication used to prevent itching of the eyes associated with allergies.
Jan 1, 2003 - (aprepitant) blocks the actions of chemicals in the body that may cause nausea and vomiting. Used to prevent nausea and vomiting associated with cancer chemotherapy.
Jan 1, 2003 - (emtricitabine) is a type of medicine called an HIV (human immunodeficiency virus) nucleoside reverse transcriptase inhibitor (NRTI). Emtricitabine is used with other anti-HIV medicines to treat people with HIV infection.
Jan 1, 2003 - (agalsidase) a man-made form of the naturally-occurring enzyme a-galactosidase A. Deficiency of the enzyme a-galactosidase A is called Fabry disease. Agalsidase beta reduces deposits of globotriaosylceramide (GL-3) in the kidneys and other certain other cells in the body. Used in the treatment of Fabry disease.
Jan 1, 2003 - (gemifloxacin) a fluoroquinolone antibiotic. Gemifloxacin is used to treat bacterial infections such as bronchitis and pneumonia.
Jan 1, 2003 - (Influenza Virus Vaccine) is a live trivalent nasally administered vaccine intended for active immunization for the prevention of influenza.
Jan 1, 2003 - (enfuvirtide) an antiviral medication in a category of human immunodeficiency virus (HIV) medicines called fusion inhibitors. Enfuvirtide blocks the ability of HIV to bind to CD4 cells in the body. Used in combination with other medicines to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Enfuvirtide is not a cure for HIV or AIDS.
Jan 1, 2003 - Iressa (gefitinib) is a tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have specific epidermal growth factor receptor (EGFR) gene mutations as detected by an FDA-approved test.
Jan 1, 2003 - (vardenafil) is used to treat erectile dysfunction (impotence).
Jan 1, 2003 - (fosamprenavir) is a protease inhibitor used in combination with other antiretroviral medicines to treat the human immunodeficiency virus (HIV), which causes the acquired immunodeficiency syndrome (AIDS).
Jan 1, 2003 - (memantine) is used in the treatment of moderate to severe dementia associated with Alzheimer’s disease.
Jan 1, 2003 - (abarelix) is used in the palliative treatment of advanced prostate cancer.
Jan 1, 2003 - (co-packaged aspirin and pravastatin) together, aspirin and pravastatin are used to slow the progression of atherosclerosis (fatty deposits in the arteries) and to reduce the risk of heart attack, stroke, and transient ischemic attack (TIA or "mini-stroke").
Jan 1, 2003 - (efalizumab) is an immunosuppressant used in the treatment of psoriasis.
Jan 1, 2003 - (atazanavir) is an anti-HIV medicine called a protease inhibitor. Atazanavir is used with other anti-HIV medicines to treat people who are infected with the human immunodeficiency virus (HIV).
Jan 1, 2003 - (levonorgestrel / ethinyl estradiol tablets) is an extended-cycle oral contraceptive indicated for the prevention of pregnancy.
Jan 1, 2003 - (pegvisomant) a manufactured protein similar to human growth hormone (GH). Pegvisomant binds to the same receptor in the body as growth hormone, and blocks the effects of growth hormone. Used for the treatment of acromegaly.
Jan 1, 2003 - (testosterone buccal system) allows for the slow release and absorption of testosterone through gum and cheek surfaces. Striant is used to treat men with low testosterone levels.
Jan 1, 2003 - (alfuzosin) is in a class of drugs called alpha-adrenergic blockers. Alfuzosin is used in adult men to treat benign prostatic hyperplasia (BPH).
Jan 1, 2003 - (bortezomib) interferes with the growth of some cancer cells. Used in treatment of the blood cancer, multiple myeloma.
Jan 1, 2003 - (omalizumab) is a recombinant DNA-derived humanized IgG1 monoclonal antibody that selectively binds to human immunoglobulin E (IgE). Omalizumab is used to treat moderate to severe persistent asthma.
Jan 1, 2003 - (miglustat) reduces the formation of the protein glucosylceramide in the body. Individuals with type 1 Gaucher disease (a hereditary disorder) cannot break down glucosylceramide effectively. Therefore, it may build up in the tissues and cause problems. Miglustat is used in the treatment of mild to moderate type 1 Gaucher disease by people who cannot receive enzyme replacement therapy.